Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
Chang-Wook Nam, Dong-Soo Kim, Jianyong Li, Marie T. Baccara-Dinet, Ivy Li, Ji-Hyun Kim, Chong-Jin Kim
Korean J Intern Med. 2019;34(6):1252-1262. Published online 2018 Sep 1 DOI: https://doi.org/10.3904/kjim.2018.133
Citations to this article as recorded by 
Biotechnology Approaches for the Treatment of Dyslipidemia
Cinzia Parolini
Cardiovascular Drugs and Therapy.2021; 35(1): 167. CrossRef
ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand
Yaling Han, Jiyan Chen, Vijay Kumar Chopra, Shuyang Zhang, Guohai Su, Changsheng Ma, Zhouqing Huang, Yingyan Ma, Zhuhua Yao, Zuyi Yuan, Qiang Zhao, Srun Kuanprasert, Marie T. Baccara-Dinet, Garen Manvelian, Jianyong Li, Rui Chen
Journal of Clinical Lipidology.2020; 14(1): 98. CrossRef
An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome
Heinz Drexel, Andrew J S Coats, Ilaria Spoletini, Claudio Bilato, Vincenzo Mollace, Pasquale Perrone Filardi, Giuseppe M C Rosano
European Heart Journal - Cardiovascular Pharmacotherapy.2020; 6(2): 115. CrossRef
Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
Han Joon Bae, Yun-Kyeong Cho, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Seongwook Han, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim, Jae-Kean Ryu, Deug Young Nah, Chang-Wook Nam
The Korean Journal of Internal Medicine.2020; 35(2): 342. CrossRef